Standard BioTools (LAB) Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
Go back to Standard BioTools (LAB) Announces Preliminary Fourth Quarter and Full Year 2023 Revenue| Labranche & Co (NASDAQ: LAB) | Delayed: 0.65 -0.01 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.66 | 52 Week High | $4.47 | |||
| Open | $0.66 | 52 Week Low | $3.02 | |||
| Day High | $0.66 | P/E | N/A | |||
| Day Low | $0.64 | EPS | $-1.56 | |||
| Volume | 1,973,135 | |||||

